Complications and Optimalisation of Mesalazine and Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease

doi 10.33612/diss.98535663
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

University of Groningen Press